Cite
HARVARD Citation
Contreras, C. et al. (2021). Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B‐acute lymphoblastic leukemia. Pediatric blood & cancer. 68 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Contreras, C. et al. (2021). Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B‐acute lymphoblastic leukemia. Pediatric blood & cancer. 68 (1), p. n/a. [Online].